{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:47:03Z","timestamp":1777506423582,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T00:00:00Z","timestamp":1470614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Radiation Medicine Department at NorthShore University HealthSystem"},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation (BMGF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejmech.2016.08.002","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T17:53:03Z","timestamp":1470765183000},"page":"895-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity"],"prefix":"10.1016","volume":"123","author":[{"given":"Maria V.","family":"Papadopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Bloomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard S.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane R.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Szular","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.08.002_bib1","series-title":"Human African Trypanosomiasis and Leishmaniasis","first-page":"975","author":"Research priorities for Chagas disease","year":"2012"},{"key":"10.1016\/j.ejmech.2016.08.002_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2016.08.002_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmech.2016.08.002_bib4","doi-asserted-by":"crossref","first-page":"e2300","DOI":"10.1371\/journal.pntd.0002300","article-title":"An unfolding tragedy of Chagas disease in North America","volume":"7","author":"Hotez","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.333.6045.934","article-title":"Infectious diseases. A tropical disease hits the road","volume":"333","author":"Leslie","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2016.08.002_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1590\/0074-0276140236","article-title":"Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries","volume":"109","author":"Coura","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2016.08.002_bib7","unstructured":"DNDi-website available: http:\/\/www.dndi.org\/diseases-projects\/diseases\/chagas\/current-treatment.html."},{"key":"10.1016\/j.ejmech.2016.08.002_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ejmech.2016.08.002_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2016.08.002_bib10","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1371\/journal.pntd.0000584","article-title":"Control of visceral leishmaniasis in Latin America \u2014 a systematic review","volume":"4","author":"Romero","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Van Griensven","year":"2010","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib12","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1021\/jm201215n","article-title":"Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-Chagasic agents","volume":"54","author":"Papadopoulou","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib13","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1021\/jm300508n","article-title":"Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential anti-trypanosomal agents","volume":"55","author":"Papadopoulou","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib14","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1016\/j.bmc.2013.08.022","article-title":"Novel 3-nitro-1H-1,2,4-triazole-bearing piperazines and 2-amino-benzothiazoles as anti-Chagasic agents","volume":"21","author":"Papadopoulou","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib15","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4155\/fmc.13.108","article-title":"Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: In\u00a0vivo studies","volume":"5","author":"Papadopoulou","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejmech.2014.09.045","article-title":"Novel nitro(triazole\/imidazole)-based heteroarylamides\/sulfonamides as potential antitrypanosomal agents","volume":"87","author":"Papadopoulou","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/jm5015742","article-title":"Novel 3-nitrotriazole-based amides and carbinols as bifunctional anti-Chagasic agents","volume":"58","author":"Papadopoulou","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejmech.2015.08.042","article-title":"3-Nitrotriazole-based piperazides as potent antitrypanosomal agents: In\u00a0vitro and in\u00a0vivo evaluation","volume":"103","author":"Papadopoulou","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.actatropica.2013.07.022","article-title":"Evaluating the developmental toxicity of trypanocidal nitroaromatic compounds on zebrafish","volume":"128","author":"Buchanan-Kilbey","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2016.08.002_bib20","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A\u00a0mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.ejmech.2016.08.002_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2016.08.002_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2010.11.010","article-title":"Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6","volume":"176","author":"Baker","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2016.08.002_bib23","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2174\/156802611796575894","article-title":"Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives","volume":"11","author":"Wilkinson","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib24","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1016\/j.bmc.2015.08.014","article-title":"Discovery of potent nitrotriazole-based antitrypanosomal agents: In\u00a0vitro and in\u00a0vivo evaluation","volume":"23","author":"Papadopoulou","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib25","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2016.08.002_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/infdis\/jit042","article-title":"VNI cures acute and chronic experimental Chagas disease","volume":"208","author":"Villalta","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib27","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1021\/jm400012e","article-title":"Antitrypanosomal lead discovery: identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth","volume":"56","author":"Andriani","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv228","article-title":"VFV as a new effective CYP51 structure-derived drug candidate for Chagas disease and visceral leishmaniasis","author":"Lepesheva","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","article-title":"Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms","volume":"1770","author":"Lepesheva","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2016.08.002_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10409238309102790","article-title":"Sterol structure and membrane function","volume":"14","author":"Bloch","year":"1983","journal-title":"CRC Crit. Rev. Biochem."},{"issue":"Suppl1","key":"10.1016\/j.ejmech.2016.08.002_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2016.08.002_bib32","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1074\/jbc.M109.067470","article-title":"Crystal structures of Trypanosoma brucei sterol 14 alpha-demethylase and implications for selective treatment of human infections","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.08.002_bib33","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1371\/journal.pntd.0000440","article-title":"Advancing drug innovation for neglected diseases\u2014criteria for lead progression","volume":"3","author":"Nwaka","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/md8010047","article-title":"Inhibitory activity of marine sponge-derived natural products against parasitic protozoa","volume":"8","author":"Orhan","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2016.08.002_bib35","doi-asserted-by":"crossref","first-page":"e2844","DOI":"10.1371\/journal.pntd.0002844","article-title":"Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics","volume":"8","author":"Trochine","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-6851(96)02722-3","article-title":"Inhibition of Trypanosoma cruzi and T-brucei NADH fumarate reductase by benzindazole and anthelmintic imidazole derivatives","volume":"82","author":"Turrens","year":"1996","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2016.08.002_bib37","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/342415","article-title":"Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-\u03b3 in mediating parasitologic cure","volume":"186","author":"Romanha","year":"2002","journal-title":"Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.08.002_bib38","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.01213-09","article-title":"Exploiting the drug-activating properties of a novel trypanosomal nitroreductase","volume":"54","author":"Hall","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.08.002_bib39","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1128\/AAC.01227-12","article-title":"Targeting the substrate preference of a type I nitroreductase to develop anti-trypanosomal quinone-based prodrugs","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.08.002_bib40","doi-asserted-by":"crossref","first-page":"e1298","DOI":"10.1371\/journal.pntd.0001298","article-title":"Activity in\u00a0vivo of anti-trypanosoma cruzi compounds selected from a high throughput screening","volume":"5","author":"Andriani","year":"2011","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416306456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416306456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T10:00:38Z","timestamp":1568282438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416306456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"alternative-id":["S0223523416306456"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.002","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}